Federal contract award
75N90025P00558
UVADEX (METHOXSALEN) 20MCG/ML; STERILE SOLN NDC# 64067-216-12 THERAKOS INC:1232217 [25-008095]
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INSTITUTES OF HEALTH - CC |
| NAICS | 325412 — Pharmaceutical Preparation Manufacturing |
| PSC | 6505 — Drugs and Biologicals |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $11.2K |
| Current contract value | $11.2K |
| Potential contract value / ceiling | $11.2K |
| Start date | Jul 10, 2025 |
| Current end date | Sep 1, 2025 |
| Potential end date | Sep 1, 2025 |
| Latest award activity | Jul 10, 2025 |
| Source loaded | Aug 15, 2026 |
Funding and modification history
Showing the latest 1 of 1 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jul 10, 2025 | 0 | $11.2K | UVADEX (METHOXSALEN) 20MCG/ML; STERILE SOLN NDC# 64067-216-12 THERAKOS INC:1232217 [25-008095] |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.